Journal
CELL HOST & MICROBE
Volume 28, Issue 4, Pages 586-+Publisher
CELL PRESS
DOI: 10.1016/j.chom.2020.08.004
Keywords
-
Categories
Funding
- National Institutes of Health [R35GM119850, NNF10CC1016517, R01AI139238, R01AI147884-01A1S1, U01CA207824, P41GM103390, P41GM103490, U01GM125267, R01GM130915]
- Massachusetts Consortium on Pathogen Readiness
Ask authors/readers for more resources
The SARS-CoV-2 betacoronavirus uses its highly glycosylated trimeric Spike protein to bind to the cell surface receptor angiotensin converting enzyme 2 (ACE2) glycoprotein and facilitate host cell entry. We utilized glycomics-informed glycoproteomics to characterize site-specific microheterogeneity of glycosylation for a recombinant trimer Spike mimetic immunogen and for a soluble version of human ACE2. We combined this information with bioinformatics analyses of natural variants and with existing 3D structures of both glycoproteins to generate molecular dynamics simulations of each glycoprotein both alone and interacting with one another. Our results highlight roles for glycans in sterically masking polypeptide epitopes and directly modulating Spike-ACE2 interactions. Furthermore, our results illustrate the impact of viral evolution and divergence on Spike glycosylation, as well as the influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available